Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónWO1998019701 A1
Tipo de publicaciónSolicitud
Número de solicitudPCT/US1997/020388
Fecha de publicación14 May 1998
Fecha de presentación7 Nov 1997
Fecha de prioridad8 Nov 1996
También publicado comoCA2270619A1, EP0963204A1, US5830461, US6103230
Número de publicaciónPCT/1997/20388, PCT/US/1997/020388, PCT/US/1997/20388, PCT/US/97/020388, PCT/US/97/20388, PCT/US1997/020388, PCT/US1997/20388, PCT/US1997020388, PCT/US199720388, PCT/US97/020388, PCT/US97/20388, PCT/US97020388, PCT/US9720388, WO 1998/019701 A1, WO 1998019701 A1, WO 1998019701A1, WO 9819701 A1, WO 9819701A1, WO-A1-1998019701, WO-A1-9819701, WO1998/019701A1, WO1998019701 A1, WO1998019701A1, WO9819701 A1, WO9819701A1
InventoresTimothy R. Billiar, Edith Tzeng, Larry L. Ii Shears, David A. Geller, Howard David James Edington
SolicitanteUniversity Of Pittsburgh Of The Commonwealth System Of Higher Education
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos:  Patentscope, Espacenet
Methods for promoting wound healing and treating transplant-associated vasculopathy
WO 1998019701 A1
Descripción  disponible en inglés
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
WO1996000006A1 *20 Jun 19954 Ene 1996University Of Pittsburgh Of The Commonwealth System Of Higher EducationInducible nitric oxide synthase gene for treatment of disease
WO1996005319A1 *11 Ago 199522 Feb 1996Arch Development CorporationGenetically engineered cells that produce dopamine
WO1997033980A1 *15 Mar 199618 Sep 1997The General Hospital CorporationTransgenic animals having a disrupted endothelial nitric oxide synthase gene and methods of use
Otras citas
Referencia
1 *MCNAMARA ET AL: "L-ARGININE INHIBITS BALLOON CATHETER-INDUCED INTIMAL HYPERPLASIA", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 193, no. 1, 1993, pages 291 - 296, XP002059683
2 *SHABANI ET AL: "ENHANCEMENT OF WOUND REPAIR WITH A TOPICALLY APPLIED NITRIC OXIDE-RELEASING POLYMER", WOUND REPAIR AND REGENERATION, vol. 4, no. 3, July 1996 (1996-07-01) - September 1996 (1996-09-01), pages 353 - 362, XP002059681
3 *SHEARS ET AL: "CYCLOSPORINE INHIBITS INDUCIBLE NITRIC OXIDE SYNTHASE (INOS) EXPRESSION IN AORTIC ALLOGRAFTS: AN ETIOLOGY FOR ALLOGRAFT VASCULOPATHY", PROCEEDINGS FOR THE 51ST ANNUAL SESSIONS OF THE OWEN H. WANGENSTEEN SURGICAL FORUM 1996 CLINICAL CONGRESS, 6 October 1996 (1996-10-06) - 11 October 1996 (1996-10-11), pages 451 - 452, XP002059682
4 *SHEARS ET AL: "INDUCIBLE NITRIC OXIDE SYNTHASE SUPPRESSES THE DEVELOPMENT OF ALLOGRAFT ARTERIOSCLEROSIS", JOURNAL OF CLINICAL INVESTIGATION, vol. 100, no. 8, 15 October 1997 (1997-10-15), pages 2035 - 2042, XP002059686
5 *TZENG ET AL: "EXPRESSION OF HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE IN A TETRAHYDROBIOPTERIN (H4B)-DEFICIENT CELL LINE: H4B PROMOTES ASSEMBLY OF ENZYME SUBUNITS INTO AN ACTIVE DIMER", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, USA, vol. 92, 1995, pages 11771 - 11775, XP002059685
6 *VON DER LEYEN ET AL: "GENE THERAPY INHIBITING NEOINTIMAL VASCUALR LESION: IN VIVO TRANSFER OF ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE GENE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES,USA, vol. 92, 1995, pages 1137 - 1141, XP002059684
Clasificaciones
Clasificación internacionalC12N15/86, A61P17/02, A61K38/00, C12N9/02, C12N15/53, C12N9/06, A61K38/50, A61K48/00, A61K38/44, A61K45/00
Clasificación cooperativaA61K38/44, C12N2800/108, C12N9/0075, C12N2830/42, C12N15/86, A61K31/519, C12N9/0022, A61K48/00, C12N9/0071, C12Y114/13039, C12N2840/20, C12N2840/203, C12N2710/10343
Clasificación europeaC12N9/00P8B3, C12N9/00P30C39, C12N15/86, C12N9/00P30, C12Y114/13039, A61K38/44, A61K38/50
Eventos legales
FechaCódigoEventoDescripción
14 May 1998AKDesignated states
Kind code of ref document: A1
Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM
14 May 1998ALDesignated countries for regional patents
Kind code of ref document: A1
Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT
2 Jul 1998DFPERequest for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
30 Sep 1998121Ep: the epo has been informed by wipo that ep was designated in this application
4 May 1999ENPEntry into the national phase in:
Ref country code: CA
Ref document number: 2270619
Kind code of ref document: A
Format of ref document f/p: F
Ref document number: 2270619
Country of ref document: CA
10 May 1999ENPEntry into the national phase in:
Ref country code: JP
Ref document number: 1998 521815
Kind code of ref document: A
Format of ref document f/p: F
8 Jun 1999WWEWipo information: entry into national phase
Ref document number: 1997946907
Country of ref document: EP
9 Sep 1999REGReference to national code
Ref country code: DE
Ref legal event code: 8642
15 Dic 1999WWPWipo information: published in national office
Ref document number: 1997946907
Country of ref document: EP
14 Jun 2002WWRWipo information: refused in national office
Ref document number: 1997946907
Country of ref document: EP
12 Sep 2002WWWWipo information: withdrawn in national office
Ref document number: 1997946907
Country of ref document: EP